The external pacemakers market is projected to grow from USD 1.9 billion in 2025 to USD 2.6 billion by 2035, at a CAGR of 3.4%. Transvenous pacing will dominate with a 47.6% market share, while single chamber will lead the modality segment with a 53.8% share.